Enzo Biochem Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
47.17 M |
Public Float |
44.43 M |
Enzo Biochem Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$0.04 |
Market Cap |
$173.58 M |
Shares Outstanding |
47.56 M |
Public Float |
43.75 M |
Address |
60 Executive Boulevard New York New York 11735 United States |
Employees | - |
Website | http://www.enzo.com |
Updated | 07/08/2019 |
Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. |